Calcium Acetate NDC 82804-968

NDC codes

FDA NDC Directory

Product NDC (as listed)82804-968Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82804-0968Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
82804-968-00	82804096800	100 CAPSULE in 1 BOTTLE (82804-968-00)Marketed from Jun 25, 2025
82804-968-20	82804096820	20 CAPSULE in 1 BOTTLE (82804-968-20)Marketed from Jun 25, 2025
82804-968-30	82804096830	30 CAPSULE in 1 BOTTLE (82804-968-30)Marketed from Jun 25, 2025
82804-968-55	82804096855	500 CAPSULE in 1 BOTTLE (82804-968-55)Marketed from Jun 25, 2025
82804-968-60	82804096860	60 CAPSULE in 1 BOTTLE (82804-968-60)Marketed from Jun 25, 2025
82804-968-64	82804096864	240 CAPSULE in 1 BOTTLE (82804-968-64)Marketed from Jun 25, 2025
82804-968-72	82804096872	120 CAPSULE in 1 BOTTLE (82804-968-72)Marketed from Jun 25, 2025
82804-968-78	82804096878	180 CAPSULE in 1 BOTTLE (82804-968-78)Marketed from Jun 25, 2025
82804-968-90	82804096890	90 CAPSULE in 1 BOTTLE (82804-968-90)Marketed from Jun 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcium Acetate
Generic name (nonproprietary): calcium acetate
Active ingredients: Calcium acetate — 667 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203179
Marketing start: Jun 13, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 82804-968_80c15366-9420-41c2-8817-b9c39ddfcec1SPL ID 80c15366-9420-41c2-8817-b9c39ddfcec1SPL set ID 80c15366-9420-41c2-8817-b9c39ddfcec1RxCUI 359296UNII Y882YXF34XUPC 0382804968305
Pharmacologic class: Blood Coagulation Factor; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482804096800 followed by a unit qualifier and the quantity

Package 82804-0968-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2025.

Indications (excerpt from the label)

1. INDICATIONS & USAGE Calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). • Calcium acetate capsules are a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203179

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203179
Product	Strength	Form · route	Labeler	Product NDC
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	Westminster Pharmaceuticals, LLC	69367-411
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	AvPAK	50268-203